ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -90.0% | 149 | -88.6% | 0.00% | -90.9% |
| Q4 2021 | $110,000 | -53.4% | 1,307 | -50.2% | 0.01% | -8.3% |
| Q3 2021 | $236,000 | +47.5% | 2,623 | +56.1% | 0.01% | +71.4% |
| Q2 2021 | $160,000 | -28.9% | 1,680 | -15.1% | 0.01% | -41.7% |
| Q1 2021 | $225,000 | -11.4% | 1,979 | -36.1% | 0.01% | -25.0% |
| Q3 2020 | $254,000 | +229.9% | 3,098 | +218.4% | 0.02% | +220.0% |
| Q2 2020 | $77,000 | +1440.0% | 973 | +826.7% | 0.01% | – |
| Q1 2020 | $5,000 | 0.0% | 105 | -15.3% | 0.00% | – |
| Q3 2019 | $5,000 | -87.8% | 124 | -79.3% | 0.00% | -100.0% |
| Q1 2019 | $41,000 | +583.3% | 598 | +321.1% | 0.00% | +200.0% |
| Q4 2018 | $6,000 | +100.0% | 142 | +91.9% | 0.00% | – |
| Q4 2017 | $3,000 | -50.0% | 74 | -25.3% | 0.00% | -100.0% |
| Q2 2017 | $6,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |